Text Size

Prospective Randomized Trial Comparing Two Techniques of Sleeve Gastrectomy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2008 by Hospital Universitari de Bellvitge.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Hospital Universitari de Bellvitge
ClinicalTrials.gov Identifier:
NCT00793728
First received: November 18, 2008
Last updated: NA
Last verified: October 2008
History: No changes posted
  Purpose

This study compares if there is any difference doing antrectomy while performing a sleeve gastrectomy for treating morbid obesity. The investigators compare the differences between leaving or not leaving the antrum in terms of food tolerance, weight lost and quality of life.


Condition Intervention
Morbid Obesity
 Procedure: Sleeve gastrectomy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Official Title: Prospective Randomized Trial Comparing Two Techniques of Sleeve Gastrectomy

Resource links provided by NLM:

MedlinePlus related topics: Obesity
U.S. FDA Resources

Further study details as provided by Hospital Universitari de Bellvitge:

Primary Outcome Measures:
  • Weight lose [ Time Frame: One year ] [ Designated as safety issue: Yes ]
  • Food tolerance [ Time Frame: One year ] [ Designated as safety issue: Yes ]
  • Quality of life [ Time Frame: One year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Metabolic syndrome outcome [ Time Frame: One year ] [ Designated as safety issue: No ]

Estimated Enrollment: 52
Study Start Date: October 2008
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Antrectomy Procedure: Sleeve gastrectomy
Perform a gastrectomy guided by a 38F catheter and parallel to the small curvature of the stomach
Active Comparator: Without antrectomy Procedure: Sleeve gastrectomy
Perform a gastrectomy guided by a 38F catheter and parallel to the small curvature of the stomach

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • BMI>40 kg/m2
  • Age >18 years old
  • Eligible for laparoscopic surgery

Exclusion Criteria:

  • Prior bariatric surgery
  • Sleeve gastrectomy as a part of a duodenal switch
  • Second time surgery before 18 months
  • Other procedures done during the surgery
  • Conversion to laparotomy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00793728

Contacts
Contact: Amador Garcia Ruiz de Gordejuela, Consultant +3493607500 ext 7621 agrgordejuela@bellvitgehospital.cat

Locations
Spain
Hospital Universitari de Bellvitge Recruiting
L'Hospitalet de Llobregat, Barcelona, Spain, 08907
Contact: Amador Garcia Ruiz de Gordejuela, Consultant     +3493607500 ext 7621     agrgordejuela@bellvitgehospital.cat    
Sponsors and Collaborators
Hospital Universitari de Bellvitge
Investigators
Principal Investigator: Amador Garcia Ruiz de Gordejuela, Consultant Consultant of Surgery
Principal Investigator: Jordi Pujol Gebelli, Consultant Consultant of Surgery
Principal Investigator: Carles Masdevall Noguera, Consultant Consultant of Surgery
  More Information

No publications provided

Responsible Party: Carles Masdevall Noguera, Hospital Universitari de Bellvitge
ClinicalTrials.gov Identifier: NCT00793728     History of Changes
Other Study ID Numbers: PR131/08
Study First Received: November 18, 2008
Last Updated: November 18, 2008
Health Authority: Spain: Comité Ético de Investigación Clínica

Keywords provided by Hospital Universitari de Bellvitge:
Morbid obesity
High risk

Additional relevant MeSH terms:
Obesity
Obesity, Morbid
Overnutrition
Nutrition Disorders
 Overweight
Body Weight
Signs and Symptoms

ClinicalTrials.gov processed this record on May 23, 2013